Nu Skin (NUS)

• Market cap: $332M
• 1 day: -1.18%
• 5 days: 1.21%
• 1 month: -12.45%
• 3 months: -9.36%
• 6 months: -35.77%
• Year to date: -67.13%
• 1 year: -67.13%
• 5 years: -83.51%
• 10 years: -84.91%
• Sector: Healthcare
• Industry: Drugs, Proprietaries & Druggists Sundries

About: Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

Employees: 15,200

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 203 [Q2] → 203 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 54

6% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 64

9.01% less ownership

Funds ownership: 87.3% [Q2] → 78.29% (-9.01%) [Q3]

37% less capital invested

Capital invested by funds: $457M [Q2] → $287M (-$170M) [Q3]

84% less call options, than puts

Call options by funds: $94K | Put options by funds: $577K

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $6.75 1% upside
• Avg. target: $6.88 3% upside
• High target: $7 5% upside

2 analyst ratings

• positive: 0 0%
• neutral: 2 100%
• negative: 0 0%

DA Davidson Linda Bolton Weiser 40% 1-year accuracy 42 / 105 met price target	5% upside $7	Neutral Maintained	20 Dec 2024
Citigroup Chasen Bender 0% 1-year accuracy 0 / 1 met price target	1% upside $6.75	Neutral Maintained	22 Oct 2024